Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // December 18th, 2009 // 6:39 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Merck hired Michael Rosenblatt as executive vice president and chief medical officer. He’s been the dean of Tufts University School of Medicine since 2003 and before that, was a professor of medicine at Harvard Medical School and Chief of the Division of Bone and Mineral Metabolism Research at Beth Israel Deaconess Medical Center (BIDMC).
The FDA named Ralph Tyler as chief counsel;
Celgene added Carrie Cox to its board;
Lilly promoted Derica Rice to exec vp, global services and cfo;
Ultroid Technologies hired Cliff McIntosh as chief executive;
AEterna Zentaris added Pierre Lapalme to its board;
Clearstone Central Laboratories promoted Lewis Cameron to ceo;
Questcor Pharmaceuticals added Louis Silverman to its board;
GVK Biosciences named Cecil Pickett as scientific advisor to its board,
Ladder thx to Flickr Creative Commons Robert CB
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Aeterna Zentaris, Celgene, Clearstone Central Laboratories, Eli Lilly, GVK Biosciences, Merck, Questcor Pharmaceuticals, Ultroid Technologies